David Baker

 Interim CEO
Alcobra Pharma
Israel

Business Expert Clinical Sciences
Biography

  Mr. Baker graduated Magna Cum Laude with a bachelor's degree in Economics and Computer Science from Duke University. He earned a Master of Business Administration in Marketing from Duke's Fuqua School of Business.

Research Intrest

  Mr. Baker joined Alcobra in January 2014 as the Chief Commercial Officer and effective June 1, 2017 was appointed interim CEO. Prior to joining Alcobra, he worked at Shire for 10 years, most recently as Vice President of Commercial Strategy and New Business in the Neuroscience Business Unit. Previously, he served as Global General Manager for Vyvanse® where he led the launch of Vyvanse and led global expansion efforts including successful establishment of a partnership in Japan and launches in Canada and Brazil. Prior to that, Mr. Baker served as Vice President of Marketing for all of Shire's ADHD products.

Global Scientific Words in Clinical Sciences